Daniel Delev

Impact of polymorphisms of the major histocompatibility complex class II, interleukin‐10, tumor necrosis factor‐α and cytotoxic T‐lymphocyte antigen‐4 genes on inhibitor development in severe hemophilia A

A. Pavlova, Daniel Delev, Sébastien Lacroix‐Desmazes et al. · Journal of Thrombosis and Haemostasis · 2009 · 170 citations

Histocompatibility, Immunogenetics, Tumor Necrosis Factor‐α +13

Molecular basis of antithrombin deficiency

Daniel Delev, Christof Geisen, Michael Spannagl et al. · Thrombosis and Haemostasis · 2011 · 107 citations

Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays

Anna Pavlova, Daniel Delev, Behnaz Pezeshkpoor et al. · Thrombosis and Haemostasis · 2014 · 65 citations

Immunohematology, Genetics, Immunology +17

NOTCH4 gene polymorphisms as potential risk factors for brain arteriovenous malformation development and hemorrhagic presentation

Daniel Delev, Anna Pavlova, Alexander Grote et al. · Journal of neurosurgery · 2016 · 36 citations

Avm Patients, Genetics, Genetic Epidemiology +21

<i>Factor 5</i> mutation profile in German patients with homozygous and heterozygous factor V deficiency

Daniel Delev, Anna Pavlova, Stefan Heinz et al. · Haemophilia · 2009 · 30 citations

Immunodeficiencies, Genetics, Pathology +19